Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EpiCept's crolibulin enters phase I/II trial in anaplastic thyroid cancer

Dec. 17, 2010

Tesaro gains development rights to antiemetic rolapitant hydrochloride

Dec. 16, 2010

Orion identifies novel inhibitors of MT-SP1

Dec. 16, 2010

MGN-1601 enters phase I/II study in advanced renal cancer

Dec. 16, 2010

MLN-0905 has antitumor effects in murine model of diffuse large B-cell lymphoma

Dec. 16, 2010

Phase I data support safety of BIIB-021 plus trastuzumab in HER2-positive breast cancer

Dec. 16, 2010

ONO-013105 synergizes with rituximab in models of MCL and advances in phase I trial

Dec. 16, 2010

HG-829 reverses resistance to antineoplastic agents in vitro and in vivo

Dec. 16, 2010

Phase II trial of EGEN-001 in advanced ovarian cancer opens enrollment

Dec. 15, 2010

CCX-721 has antitumor effects in murine model of multiple myeloma

Dec. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...